GB1392272A - 3-formylrifamycin azines - Google Patents
3-formylrifamycin azinesInfo
- Publication number
- GB1392272A GB1392272A GB1519173A GB1519173A GB1392272A GB 1392272 A GB1392272 A GB 1392272A GB 1519173 A GB1519173 A GB 1519173A GB 1519173 A GB1519173 A GB 1519173A GB 1392272 A GB1392272 A GB 1392272A
- Authority
- GB
- United Kingdom
- Prior art keywords
- rifamycin
- derivatives
- formylrifamycin
- aliphatic
- divalent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BBNQHOMJRFAQBN-UPZFVJMDSA-N 3-formylrifamycin sv Chemical compound OC1=C(C(O)=C2C)C3=C(O)C(C=O)=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O BBNQHOMJRFAQBN-UPZFVJMDSA-N 0.000 title abstract 3
- 125000001931 aliphatic group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- -1 cycloaliphatic Chemical group 0.000 abstract 3
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical class OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 abstract 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229930189077 Rifamycin Natural products 0.000 abstract 1
- HJYYPODYNSCCOU-ZDHWWVNNSA-N Rifamycin SV Natural products COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C)cc(O)c4c3C2=O HJYYPODYNSCCOU-ZDHWWVNNSA-N 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 abstract 1
- 229960003292 rifamycin Drugs 0.000 abstract 1
- 229940109171 rifamycin sv Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2507572 | 1972-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1392272A true GB1392272A (en) | 1975-04-30 |
Family
ID=11215624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1519173A Expired GB1392272A (en) | 1972-05-31 | 1973-03-29 | 3-formylrifamycin azines |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS516679B2 (es) |
| AR (2) | AR198663A1 (es) |
| AT (1) | AT323885B (es) |
| BE (1) | BE800276A (es) |
| CA (1) | CA992961A (es) |
| CH (1) | CH573433A5 (es) |
| DD (1) | DD107285A5 (es) |
| DE (1) | DE2326698A1 (es) |
| ES (1) | ES414894A1 (es) |
| FR (1) | FR2186231B1 (es) |
| GB (1) | GB1392272A (es) |
| HU (1) | HU167317B (es) |
| IE (1) | IE37481B1 (es) |
| IL (1) | IL41926A (es) |
| LU (1) | LU67695A1 (es) |
| NL (1) | NL154510B (es) |
| PL (1) | PL87112B1 (es) |
| RO (1) | RO65182A (es) |
| SE (1) | SE386444B (es) |
| SU (1) | SU514572A3 (es) |
| ZA (1) | ZA732293B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1478563A (en) * | 1975-03-05 | 1977-07-06 | Lepetit Spa | Rifamycin derivatives |
-
1973
- 1973-03-29 GB GB1519173A patent/GB1392272A/en not_active Expired
- 1973-03-30 IE IE508/73A patent/IE37481B1/xx unknown
- 1973-04-02 IL IL41926A patent/IL41926A/en unknown
- 1973-04-03 ZA ZA732293A patent/ZA732293B/xx unknown
- 1973-05-08 AR AR247892A patent/AR198663A1/es active
- 1973-05-11 CA CA171,060A patent/CA992961A/en not_active Expired
- 1973-05-18 ES ES414894A patent/ES414894A1/es not_active Expired
- 1973-05-25 NL NL737307319A patent/NL154510B/xx not_active IP Right Cessation
- 1973-05-25 DE DE2326698A patent/DE2326698A1/de active Pending
- 1973-05-29 JP JP48059434A patent/JPS516679B2/ja not_active Expired
- 1973-05-29 LU LU67695A patent/LU67695A1/xx unknown
- 1973-05-29 FR FR7319518A patent/FR2186231B1/fr not_active Expired
- 1973-05-29 AT AT468173A patent/AT323885B/de not_active IP Right Cessation
- 1973-05-29 DD DD171159A patent/DD107285A5/xx unknown
- 1973-05-29 SU SU1920394A patent/SU514572A3/ru active
- 1973-05-29 SE SE7307611*A patent/SE386444B/xx unknown
- 1973-05-29 RO RO7374946A patent/RO65182A/ro unknown
- 1973-05-30 HU HULE706A patent/HU167317B/hu unknown
- 1973-05-30 CH CH783173A patent/CH573433A5/xx not_active IP Right Cessation
- 1973-05-30 BE BE131720A patent/BE800276A/xx unknown
- 1973-05-30 PL PL1973162950A patent/PL87112B1/pl unknown
- 1973-12-19 AR AR251497A patent/AR198715A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| IL41926A0 (en) | 1973-06-29 |
| AR198663A1 (es) | 1974-07-15 |
| ES414894A1 (es) | 1976-02-01 |
| IL41926A (en) | 1976-04-30 |
| SE386444B (sv) | 1976-08-09 |
| DE2326698A1 (de) | 1973-12-13 |
| DD107285A5 (es) | 1974-07-20 |
| BE800276A (fr) | 1973-09-17 |
| AT323885B (de) | 1975-08-11 |
| RO65182A (ro) | 1981-05-30 |
| ZA732293B (en) | 1974-02-27 |
| AR198715A1 (es) | 1974-07-15 |
| CA992961A (en) | 1976-07-13 |
| NL154510B (nl) | 1977-09-15 |
| PL87112B1 (es) | 1976-06-30 |
| CH573433A5 (es) | 1976-03-15 |
| LU67695A1 (es) | 1973-08-02 |
| IE37481L (en) | 1973-11-30 |
| HU167317B (es) | 1975-09-27 |
| IE37481B1 (en) | 1977-08-03 |
| NL7307319A (es) | 1973-12-04 |
| FR2186231B1 (es) | 1976-03-05 |
| AU5616173A (en) | 1974-11-28 |
| FR2186231A1 (es) | 1974-01-11 |
| JPS516679B2 (es) | 1976-03-01 |
| JPS4942698A (es) | 1974-04-22 |
| SU514572A3 (ru) | 1976-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1305863A (es) | ||
| CA2083534A1 (en) | Indolopyrrolocarbazole derivatives | |
| MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
| ES342185A1 (es) | Procedimiento para la preparacion de compuestos de n,n' - diglicidilicos. | |
| GB1478563A (en) | Rifamycin derivatives | |
| ES463803A1 (es) | Procedimiento para la produccion de hidroxilaminas o-alqui- ladas. | |
| IE36221L (en) | Cephalosporins | |
| ES380221A1 (es) | Procedimiento para la preparacion de derivados de s-trian- zina. | |
| GB1392272A (en) | 3-formylrifamycin azines | |
| GB1194598A (en) | Benzofuran Derivatives | |
| CA2053705A1 (en) | Piperazine derivatives | |
| IE36443L (en) | 3-formylrifamycin sv derivatives | |
| GB1366283A (en) | 3-hydrazonomethyl rifamycin sv | |
| GB1316689A (en) | Trifamycin derivatives | |
| EP0034002A3 (en) | Carboxamidine derivatives | |
| IE36278B1 (en) | Pharmaceutical compositions containing benzofuran derivatives | |
| ES427763A1 (es) | Procedimiento para la preparacion de nuevos colorantes de dispersion. | |
| IE38562L (en) | 3-alkenyl derivatives of rifamycin sv | |
| GB1289189A (es) | ||
| GB1283187A (en) | Improvements in or relating to rifamycin derivatives and the preparation thereof | |
| AU624724B2 (en) | Pyrrolo(2,1-b)thiazole derivatives | |
| GB1229012A (es) | ||
| GB1445287A (en) | Derivatives of iboga type alkaloids | |
| GB1275879A (en) | Process for the preparation of isonitriles | |
| GB969031A (en) | Nitrofuryl-thiazole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |